Wnt/Ca2+/NFAT signaling maintains survival of Ph+ leukemia cells upon inhibition of Bcr-Abl.

No abstract is available for this paper.

• Publication year

  2010

• Venue

  Cancer Cell

• Publication date

  2010-07-13

• Fields of study

  Biology, Medicine

• Identifiers
  DOI 10.1016/j.ccr.2010.04.025PMID 20609354PMCID PMC2904512
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• Interaction between TAK1–TAB1–TAB2 and RCAN1–calcineurin defines a signalling nodal control point

  2009influential reference
• Treatment of Philadelphia chromosome-positive acute lymphoblastic leukemia

  2009cited by this paper
• Wnt5A/CaMKII Signaling Contributes to the Inflammatory Response of Macrophages and Is a Target for the Antiinflammatory Action of Activated Protein C and Interleukin-10

  2008cited by this paper
• The INK4-ARF (CDKN2A/B) locus in hematopoiesis and BCR-ABL-induced leukemias.

  2008cited by this paper
• The calcineurin/NFAT signaling pathway: A NOVEL therapeutic target in leukemia and solid tumors

  2008cited by this paper
• Interfering RNA-mediated purine analog resistance for in vitro and in vivo cell selection.

  2008cited by this paper
• The complex pathways of Wnt 5a in cancer progression

  2008cited by this paper
• Elevating Calcium in Th2 Cells Activates Multiple Pathways to Induce IL-4 Transcription and mRNA Stabilization1

  2008influential reference
• Ryk cooperates with Frizzled 7 to promote Wnt11-mediated endocytosis and is essential for Xenopus laevis convergent extension movements

  2008influential reference
• Crucial role of interleukin-4 in the survival of colon cancer stem cells.

  2008cited by this paper
• p53 Mediates Senescence-Like Arrest Induced by Chronic Replicational Stress

  2007cited by this paper
• Aberrant cytokine signaling in leukemia.

  2007cited by this paper
• Colon cancer stem cells dictate tumor growth and resist cell death by production of interleukin-4.

  2007cited by this paper
• Promoter analysis of human CC chemokine CCL23 gene in U937 monocytoid cells.

  2007cited by this paper
• Flying under the radar: the new wave of BCR–ABL inhibitors

  2007cited by this paper
• CaMKII regulates retinoic acid receptor transcriptional activity and the differentiation of myeloid leukemia cells.

  2007cited by this paper
• Imatinib mesylate discontinuation in patients with chronic myelogenous leukemia in complete molecular remission for more than 2 years.

  2007cited by this paper
• Faculty Opinions recommendation of Bcr-Abl stabilizes beta-catenin in chronic myeloid leukemia through its tyrosine phosphorylation.

  2007cited by this paper
• Cytokine-dependent imatinib resistance in mouse BCR-ABL+, Arf-null lymphoblastic leukemia.

  2007influential reference
• Targeting calcineurin activation as a therapeutic strategy for T-cell acute lymphoblastic leukemia

  2007cited by this paper
• INNO-406, a novel BCR-ABL/Lyn dual tyrosine kinase inhibitor, suppresses the growth of Ph+ leukemia cells in the central nervous system, and cyclosporine A augments its in vivo activity.

  2007cited by this paper
• [Treatment for Philadelphia chromosome-positive acute lymphoblastic leukemia].

  2007cited by this paper
• Aberrant cytokine signaling in leukemia

  2007cited by this paper
• Bcr‐Abl stabilizes β‐catenin in chronic myeloid leukemia through its tyrosine phosphorylation

  2007cited by this paper
• KN-93 (2-[N-(2-Hydroxyethyl)]-N-(4-methoxybenzenesulfonyl)]amino-N-(4-chlorocinnamyl)-N-methylbenzylamine), a Calcium/Calmodulin-Dependent Protein Kinase II Inhibitor, Is a Direct Extracellular Blocker of Voltage-Gated Potassium Channels

  2006cited by this paper
• Gene expression changes associated with progression and response in chronic myeloid leukemia.

  2006cited by this paper
• CaMKII-independent effects of KN93 and its inactive analog KN92: reversible inhibition of L-type calcium channels.

  2006cited by this paper
• Wnt signaling: complexity at the surface

  2006cited by this paper
• The Wingless homolog WNT5A and its receptor Frizzled-5 regulate inflammatory responses of human mononuclear cells induced by microbial stimulation.

  2006cited by this paper
• Ca2+/Calmodulin-Dependent Protein Kinase II Is a Modulator of CARMA1-Mediated NF-κB Activation

  2006cited by this paper
• Recombinant Adenoviral Vectors Can Induce Expression of p73 via the E4-orf6/7 Protein

  2006cited by this paper
• Ca2+/calmodulin-dependent protein kinase II is a modulator of CARMA1-mediated NF-kappaB activation.

  2006cited by this paper
• Loss of P-glycoprotein expression in hematopoietic stem cells does not improve responses to imatinib in a murine model of chronic myelogenous leukemia

  2005cited by this paper
• The Mechanism of Endogenous Receptor Activation Functionally Distinguishes Prototype Canonical and Noncanonical Wnts

  2005cited by this paper
• P-glycoprotein-mediated drug efflux is a resistance mechanism of chronic myelogenous leukemia cells to treatment with imatinib mesylate

  2004cited by this paper
• Arginine methylation of NIP45 modulates cytokine gene expression in effector T lymphocytes.

  2004influential reference
• A Second Canon

  2003cited by this paper
• Transcriptional regulation by calcium, calcineurin, and NFAT.

  2003cited by this paper
• Molecular mechanisms of transformation by the BCR-ABL oncogene.

  2003cited by this paper
• Dishevelled activates Ca2+ flux, PKC, and CamKII in vertebrate embryos

  2003influential reference
• Targeted inhibition of p38 MAPK promotes hypertrophic cardiomyopathy through upregulation of calcineurin-NFAT signaling.

  2003cited by this paper
• A second canon. Functions and mechanisms of beta-catenin-independent Wnt signaling.

  2003cited by this paper
• Philadelphia chromosome-positive acute lymphoblastic leukemia- current concepts and future perspectives.

  2002cited by this paper
• NFAT1 and NFAT2 are positive regulators of IL‐4 gene transcription

  2002influential reference
• Signaling of Rat Frizzled-2 Through Phosphodiesterase and Cyclic GMP

  2002influential reference
• The Wnt/calcium pathway activates NF-AT and promotes ventral cell fate in Xenopus embryos

  2002cited by this paper
• A phase 2 study of imatinib in patients with relapsed or refractory Philadelphia chromosome-positive acute lymphoid leukemias.

  2002cited by this paper
• Regulation of convergent extension in Xenopus by Wnt5a and Frizzled-8 is independent of the canonical Wnt pathway.

  2001cited by this paper
• Sequential involvement of NFAT and Egr transcription factors in FasL regulation.

  2000influential reference
• Outcome of Philadelphia Chromosome-Positive Adult Acute Lymphoblastic Leukemia

  2000cited by this paper
• Ca2+/Calmodulin-dependent Protein Kinase II Is Stimulated by Wnt and Frizzled Homologs and Promotes Ventral Cell Fates in Xenopus*

  2000cited by this paper
• The molecular biology of chronic myeloid leukemia.

  2000cited by this paper
• The temporal profile of calcineurin inhibition by cyclosporine in vivo.

  1999cited by this paper
• Interaction of Wnt and a Frizzled homologue triggers G-protein-linked phosphatidylinositol signalling

  1997cited by this paper
• Interleukin-7 Upregulates the Interleukin-2–Gene Expression in Activated Human T Lymphocytes at the Transcriptional Level by Enhancing the DNA Binding Activities of Both Nuclear Factor of Activated T Cells and Activator Protein-1

  1997cited by this paper
• Interleukin-7 upregulates the interleukin-2-gene expression in activated human T lymphocytes at the transcriptional level by enhancing the DNA binding activities of both nuclear factor of activated T cells and activator protein-1.

  1997influential reference
• NF-AT-Driven Interleukin-4 Transcription Potentiated by NIP45

  1996influential reference
• The NFAT-1 DNA binding complex in activated T cells contains Fra-1 and JunB

  1993influential reference

• G protein-coupled receptor 137B drives malignant progression and May serves as a diagnostic and prognostic biomarker in esophageal squamous cell carcinoma.

  2026cites this paper
• Frizzled receptors: gatekeepers of Wnt signaling in development and disease

  2025cites this paper
• SOHO State of the Art Updates and Next Questions: Combination Therapy in Chronic Myeloid Leukemia in Chronic Phase.

  2025cites this paper
• Class Frizzled GPCRs in GtoPdb v.2025.3

  2025cites this paper
• Drug discovery for chemotherapeutic resistance based on pathway-responsive gene sets and its application in breast cancer

  2025cites this paper
• Targeting Musashi-2 to counteract senescence and resistance in chronic myeloid leukemia: enhancing the efficacy of imatinib therapy

  2025cites this paper
• MPASL: multi-perspective learning knowledge graph attention network for synthetic lethality prediction in human cancer

  2024cites this paper
• The MYC–NFATC2 axis maintains the cell cycle and mitochondrial function in acute myeloid leukaemia cells

  2024cites this paper
• The ultimate microbial composition for correcting Th17/Treg cell imbalance and lipid metabolism disorders in osteoporosis.

  2024cites this paper
• Hyperbolic Lorentz attention for synthetic lethality prediction

  2024cites this paper
• Pharmacotherapeutic advances for chronic myelogenous leukemia: beyond tyrosine kinase inhibitors

  2024cites this paper
• Wnt regulation of hematopoietic stem cell development and disease.

  2023cites this paper
• Network regulatory mechanism of ncRNA on the Wnt signaling pathway in osteoporosis

  2023cites this paper
• Synthetic Lethality Approaches in Acute Lymphoblastic Leukemia

  2023cites this paper
• NFAT signaling dysregulation in cancer: Emerging roles in cancer stem cells.

  2023cites this paper
• Class Frizzled GPCRs in GtoPdb v.2023.1 Class Frizzled GPCRs in GtoPdb v.2023.1

  2023cites this paper
• Mast cell deficiency prevents BCR::ABL1 induced splenomegaly and cytokine elevation in a CML mouse model

  2023cites this paper
• Bioinformatics screening of colorectal-cancer causing molecular signatures through gene expression profiles to discover therapeutic targets and candidate agents

  2023cites this paper
• Molecular Mechanisms of Tyrosine Kinase Inhibitor Resistance in Chronic Myeloid Leukemia.

  2023cites this paper
• Effects of Triiodothyronine on Human Osteoblast-Like Cells: Novel Insights From a Global Transcriptome Analysis

  2022cites this paper
• BCR-ABL1 Tyrosine Kinase Complex Signaling Transduction: Challenges to Overcome Resistance in Chronic Myeloid Leukemia

  2022cites this paper
• Oral Conventional Synthetic Disease-Modifying Antirheumatic Drugs with Antineoplastic Potential: a Review

  2022cites this paper
• Developing therapeutic approaches for chronic myeloid leukemia: a review

  2022cites this paper
• Construction of chitooligosaccharide-based nanoparticles of pH/redox cascade responsive for co-loading cyclosporin A and AZD9291.

  2022cites this paper
• Class Frizzled GPCRs in GtoPdb v.2021.3

  2021cites this paper
• SynLethDB 2.0: a web-based knowledge graph database on synthetic lethality for novel anticancer drug discovery

  2021cites this paper
• Chronic myeloid leukemia stem cells: targeting therapeutic implications

  2021cites this paper
• Leukemia Stem Cells as a Potential Target to Achieve Therapy-Free Remission in Chronic Myeloid Leukemia

  2021cites this paper
• Wnt Signaling in Cancer

  2021cites this paper
• PLCG1 is required for AML1-ETO leukemia stem cell self-renewal.

  2021cites this paper
• Transcriptional Regulation by the NFAT Family in Acute Myeloid Leukaemia

  2021cites this paper
• Targeting Leukemic Stem Cells in Chronic Myeloid Leukemia: Is It Worth the Effort?

  2021cites this paper
• Wnt signaling in breast cancer: biological mechanisms, challenges and opportunities

  2020cites this paper
• Wnt Pathway: An Integral Hub for Developmental and Oncogenic Signaling Networks

  2020cites this paper
• DYRK2 controls a key regulatory network in chronic myeloid leukemia stem cells

  2020cites this paper
• NFAT2 overexpression suppresses the malignancy of hepatocellular carcinoma through inducing Egr2 expression

  2020cites this paper
• Therapeutic inhibition of FcγRIIb signaling targets leukemic stem cells in chronic myeloid leukemia

  2020cites this paper
• Combination therapy of BCR-ABL-positive B cell acute lymphoblastic leukemia by tyrosine kinase inhibitor dasatinib and c-JUN N-terminal kinase inhibition

  2020cites this paper
• A small molecule compound IX inhibits telomere and attenuates oncogenesis of drug‐resistant leukemia cells

  2020cites this paper
• Response and Resistance to BCR-ABL1-Targeted Therapies.

  2020cites this paper
• Involvement of the central nervous system in acute lymphoblastic leukemia: opinions on molecular mechanisms and clinical implications based on recent data

  2020cites this paper
• Therapeutic inhibition of FcgammaRIIb signaling targets leukemic stem cells in chronic myeloid leukemia

  2020cites this paper
• WNT Signaling in Hematological Malignancies

  2020cites this paper
• Arginine methylation of FOXP3 is crucial for the suppressive function of regulatory T cells.

  2019cites this paper
• High expression of NFAT2 contributes to carboplatin resistance in lung cancer.

  2019cites this paper
• Nfatc4 Deficiency Attenuates Ototoxicity by Suppressing Tnf-Mediated Hair Cell Apoptosis in the Mouse Cochlea

  2019cites this paper
• Energy metabolism and drug response in myeloid leukaemic stem cells

  2019cites this paper
• Dasatinib as an investigational drug for the treatment of Philadelphia chromosome-positive acute lymphoblastic leukemia in adults

  2019cites this paper
• Cyclosporine A sensitizes lung cancer cells to crizotinib through inhibition of the Ca2+/calcineurin/Erk pathway

  2019cites this paper
• The WNT Pathway Is Relevant for the BCR-ABL1-Independent Resistance in Chronic Myeloid Leukemia

  2019cites this paper
• IL-12 abrogates calcineurin-dependent immune evasion during leukemia progression.

  2019cites this paper
• Chronic myeloid leukemia stem cells

  2019cites this paper
• R-spondin signaling as a pivotal regulator of tissue development and homeostasis

  2019cites this paper
• Targeting signalling pathways and the immune microenvironment of cancer stem cells — a clinical update

  2019cites this paper
• Wnt5a promotes differentiation and development of adult‐born neurons in the hippocampus by noncanonical Wnt signaling

  2019cites this paper
• Druggable Biochemical Pathways and Potential Therapeutic Alternatives to Target Leukemic Stem Cells and Eliminate the Residual Disease in Chronic Myeloid Leukemia

  2019cites this paper
• Wnt Signaling: Pathogen Incursion and Immune Defense

  2019cites this paper
• Class Frizzled GPCRs (version 2019.4) in the IUPHAR/BPS Guide to Pharmacology Database

  2019cites this paper
• Studying Cancer Evolution and Therapeutic Responses in Different Organs: The Pros and Cons of a Broad Focus.

  2019cites this paper
• Chronic myelogenous leukemia Chronic myeloid leukemia stem cells

  2019cites this paper
• Phase Ib Results of the Rational Combination of Selumetinib and Cyclosporin A in Advanced Solid Tumors with an Expansion Cohort in Metastatic Colorectal Cancer.

  2018cites this paper
• Secreted Wnt antagonists in leukemia: A road yet to be paved.

  2018cites this paper
• Wnt Signaling in Hematological Malignancies.

  2018cites this paper
• Targeting chronic myeloid leukemia stem cells: can transcriptional program be a druggable target for cancers?

  2018cites this paper
• Deregulation of calcium homeostasis in Bcr-Abl-dependent chronic myeloid leukemia

  2018cites this paper
• FusionPathway: Prediction of pathways and therapeutic targets associated with gene fusions in cancer

  2018cites this paper
• B-cell receptor-mediated NFATc1 activation induces IL-10/STAT3/PD-L1 signaling in diffuse large B-cell lymphoma.

  2018cites this paper
• Xiao-AiPing inhibits proliferation and induces apoptosis of chronic myeloid leukemia cells through downregulating β-catenin signaling pathway

  2018cites this paper
• Overexpression of Hes1 is involved in sensitization of K562 cells to Imatinib

  2018cites this paper
• Non-canonical Wnt signalling initiates scarring in biliary disease

  2018cites this paper
• Targeting Glutamine Metabolism and Redox State for Leukemia Therapy

  2018cites this paper
• The role of the wnt receptor frizzled-8 in prostate cancer pathogenesis

  2018cites this paper
• NH4Cl affects the expression of Wnt/β-catenin pathway in hepatocytes.

  2018cites this paper
• NFATc3 mediates the sensitivity of gastric cancer cells to arsenic sulfide

  2017cites this paper
• Growth of tyrosine kinase inhibitor-resistant Philadelphia-positive acute lymphoblastic leukemia: Role of bone marrow stromal cells

  2017cites this paper
• NFAT2 is a critical regulator of the anergic phenotype in chronic lymphocytic leukaemia

  2017cites this paper
• CML cells actively evade host immune surveillance through cytokine-mediated downregulation of MHC-II expression.

  2017cites this paper
• The chronic myeloid leukemia stem cell: stemming the tide of persistence.

  2017cites this paper
• Analysis of Drug Resistance Using Kinome-Wide Functional Screens.

  2017cites this paper
• The calcineurin protein phosphatase is dispensable for BCR-ABL-induced B-ALL maintenance, propagation and response to dasatinib

  2017cites this paper
• NFATc3 mediates the sensitivity of gastric cancer cells to arsenic sulfide.

  2017cites this paper
• Pharmacogenomic considerations in the treatment of muscle-invasive bladder cancer.

  2017cites this paper
• Aberrant Wnt Signaling in Leukemia

  2016cites this paper
• Understanding the Genetic Mechanisms of Cancer Drug Resistance Using Genomic Approaches.

  2016cites this paper
• Different Balance of Wnt Signaling in Adult and Fetal Bone Marrow-Derived Mesenchymal Stromal Cells

  2016cites this paper
• Narrowing the focus: a toolkit to systematically connect oncogenic signaling pathways with cancer phenotypes

  2016cites this paper
• WNT signalling affects cell migration, invasion and the lymphoma-endothelial interplay in Hodgkin Lymphoma

  2016cites this paper
• Effective Concentration of a Multikinase Inhibitor within Bone Marrow Correlates with In Vitro Cell Killing in Therapy-Resistant Chronic Myeloid Leukemia

  2016cites this paper
• Cyclosporine A sensitizes human non-small cell lung cancer cells to gefitinib through inhibition of STAT3.

  2016cites this paper
• Proteomic analysis of imatinib-resistant CML-T1 cells reveals calcium homeostasis as a potential therapeutic target

  2016cites this paper
• ATM/G6PD-driven redox metabolism promotes FLT3 inhibitor resistance in acute myeloid leukemia

  2016influential citation
• Rôle de la signalisation calcique dans la leucémie myéloïde chronique

  2016cites this paper
• Study of Arsenic Sulfide in Solid Tumor Cells Reveals Regulation of Nuclear Factors of Activated T-cells by PML and p53

  2016cites this paper
• Molecular evolution of the multiple calmodulin-like cal genes in C. elegans and in nematodes

  2016cites this paper
• Toxicity of doxorubicin-transferrin conjugate is connected to the modulation of Wnt/β-catenin pathway in human leukemia cells.

  2015cites this paper
• Do we need more drugs for chronic myeloid leukemia?

  2015cites this paper
• RNA interference and protein expression of the four calmodulin-like genes in Caenorhabditis elegans

  2015cites this paper
• Knockout Serum Replacement Promotes Cell Survival by Preventing BIM from Inducing Mitochondrial Cytochrome C Release

  2015cites this paper
• Analyse des Transkriptionsfaktors NFAT2 in der Pathogenese der CLL

  2015cites this paper
• NFATc1 as a therapeutic target in FLT3-ITD-positive AML

  2015cites this paper